Healthnostics Obtains First Bio-Medical Application License Nanoparticle Technology Applies to Several Medical Fields
ACCESSWIRE - Wed Jan 14, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2015 / Healthnostics, Inc. (OTC Pink: HNSS) (PINKSHEETS: HNSS), announced it agreed to enter into its first bio-medical license agreement for nanoparticle therapeutic delivery applications. A "nanoparticle" is a particle exhibiting a diameter of 1-100 nanometers (billionths of a meter). The agreement allows Healthnostics to initiate an evaluation, identify ways to utilize the technology, identify development sources and create market applicability. This is the first license entered into under the Company's new Medical Therapeutic Initiative.
Healthnostics Announces New Medical Therapeutic Initiative
ACCESSWIRE - Thu Jan 08, 7:45AM CST
NEW YORK, NY / ACCESSWIRE / January 8, 2015 / Healthnostics, Inc. (OTC Pink: HNSS) (PINKSHEETS: HNSS), announced it is expanding the company's business model to seek out and enter into licensing agreements, acquisitions and investment opportunities focused on bio-medical applications and therapeutic technologies.
Healthnostics Completes Sale of BakedAmerican.com
ACCESSWIRE - Thu Dec 04, 7:17AM CST
MedBioWorld.com to be Updated Adding Medical Cannabis Reference Channel